Hypoactive sexual desire disorder in postmenopausal women

Gynecological Endocrinology

Volumn 22, Issue 6, 2006, Pages 318-323

  Nappi, Rossella ^a   Wawra, Kathrin ^b   Schmitt, Sonja ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Androgens; Libido; Natural menopause; Surgical menopause; Testosterone

Indexed keywords

ANDROGEN; ESTROGEN; ESTROGEN DERIVATIVE; GESTAGEN; SEX HORMONE; TESTOSTERONE;

CLINICAL TRIAL; DISTRESS SYNDROME; DRUG EFFICACY; DYSPAREUNIA; ENERGY; FANTASY; FEMALE; HEALTH STATUS; HORMONAL THERAPY; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; LUBRICATION; MENOPAUSE; MOOD; PHASE 3 CLINICAL TRIAL; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL SATISFACTION; SYMPTOMATOLOGY; THINKING; TREATMENT OUTCOME; VAGINA ATROPHY; WELLBEING;

FEMALE; HUMANS; MENOPAUSE; MENOPAUSE, PREMATURE; OVARIECTOMY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 33745384780     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590600762265     Document Type: Review

References (51)

1. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 7th ed. Baltimore (MD): Lippincott Williams & Wilkins; 2004. pp 25-96.
2. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-3853.
3. Davis SR, Burger H. Androgen and postmenopausal women. J Clin Endocrinol Metab 1996;81:2759-2763.
4. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002;77:S42-S48.
5. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-1030.
6. Munarriz R, Kim NN, Goldstein I, Traish AM. Biology of female sexual function. Urol Clin North Am 2002;29:685-693.
7. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990;75:26S-35S.
8. Nappi RE, Detaddei S, Ferdeghini F, Brundu B, Sommacal A, Polatti F. Role of testosterone in feminine sexuality. J Endocrinol Invest 2003;26:97-101.
9. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: a literature review. Menopause 2004;11:120-130.
10. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-358.
11. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001;76:456-460.
12. Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005;84:174-180.
13. Nappi RE, Baldaro Verde J, Polatti F, Genazzani AR, Zara C. Self-reported sexual symptoms in women attending menopause clinics. J Obstet Gynecol Invest 2002;53:181-187.
14. Zussman L, Zussman S, Sunley R, Bjornson E. Sexual response after hysterectomy-oophorectomy: recent studies and reconsideration of psychogenesis. Am J Obstet Gynecol 1981;140:725-729.
15. Asch RH, Greenblatt RB. Steroidogenesis in the postmenopausal ovary. Clin Obstet Gynecol 1977;4:85-106.
16. Lobo RA. Androgens in postmenopausal women: production, possible role, and replacement options. Obstet Gynecol Surv 2001;56:361-376.
17. Adashi EY. The climacteric ovary as a functional gonadotropin driven androgen producing gland. Fertil Steril 1994;62:20-27.
18. Burger HG. Androgen production in women. Fertil Steril 2002;77:S3-S5.
19. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metal 1976;42:247-253.
20. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995;80:1429-1430.
21. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulphate and sex hormone binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2832-2938.
22. Zumoff B, Rosenfeld RS, Strain GW, Levin J, Fukushima DK. Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 1995;51:330-333.
23. Simon J. Estrogen replacement therapy: effects on the endogenous androgen milieu. Fertil Steril 2002;77(Suppl 4):S77-S82.
24. Davis S, Tran J. Testosterone influences libido and well-being in women. Trends Endocrinol Metab 2001;12:33-37.
25. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, Goldstein I, Guay A, Leiblum S, Lobo R, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002;77:660-665.
26. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85:645-651.
27. Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. Br J Obstet Gynecol 2005;112:956-962.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
29. Basson R, Leiblum S, Brotto L, Derogatis L, Fourcroy J, Fugl-Meyer K, Graziottin A, Heiman JR, Laan E, Meston C, et al. Definitions of women's sexual dysfunctions reconsidered: advocating expansion and revision. J Psychosom Obstet Gynecol 2003;24:221-229.
30. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. J Am Med Assoc 1999;281:537-544.
31. Bachmann GA, Leiblum SR. Sexuality in sexagenarian women. Maturitas 1991;13:43-50.
32. Meston CM. Aging and sexuality. West J Med 1997;167:285-290.
33. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, Gingell C; Global Study of Sexual Attitudes and Behaviors Investigators' Group. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology 2004;64:991-997.
34. Nicolosi A. Bridging the gap between research and policy in public health: information, promotion and training. Eur J Public Health 2002;12(4 Suppl):5-128.
35. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of western European women. J Sex Med 2006;3:212-222.
36. Leiblum S, Koochaki P, Rodenberg C, Barton I, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006;13:46-56.
37. Mahoney CA, Rust J, Golombok S, Davis S, Bouchard C, Brown C, Basson R, Sarti CD, Kuznicki J, Rodenberg C, et al. Profile of Female Sexual Function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women. Menopause 2004;11:474-483.
38. Derogatis L, Rust J, Golombok S, Kuznicki J, Rodenberg C, McHorney C. A patient-generated, multinational inventory to measure distress associated with low desire. Proceedings of the Annual Meeting of the International Society for the Study of Women's Sexual Health; Oct 28-31, 2004; Atlanta (GA). p 206.
39. Modelska K, Cummings S. Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials. Am J Obstet Gynecol 2003;188:286-293.
40. Alexander JL, Kotz K, Dennerstein L, Kutner SJ, Wallen K, Notelovitz M. The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials. Menopause 2004;11:749-765.
41. Sherwin BB, Gelfand MM. Differential symptom response to parental estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985;151:153-160.
42. Davis SR, McCloud PI, Strauss BJG, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-236.
43. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 1998;43:847-856.
44. Shifren J, Braunstein G, Simon J, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688.
45. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005;165:1582-1589.
46. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226-5233.
47. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105;944-952.
48. Hill K. The demography of menopause. Maturitas 1996;23;113-127.
49. World Health Organization. Women, ageing and health. Factsheet 252 [Internet]. Geneva: WHO; 2000 Jun [cited 2004 Jan]. Available at http://www.who.int/mediacentre/factsheets/fs252/en/
50. Humphery S, Nazareth I. GPs' views on their management of sexual dysfunction. Fam Pract 2001;18:516-518.
51. Berman L, Berman J, Felder S, Pollets D, Chhabra S, Miles M, Powell JA. Seeking help for sexual function complaints: what gynecologists need to know about the female patient's experience. Fertil Steril 2003;79:572-576.